So far, the view from Wall Street tips bullish, but analysts are split on the company’s growth potential and whether or not it is fairly valued at current levels. Of analysts that have started coverage, eight have buy-equivalent ratings, five say to hold and only two recommend selling shares, according to data compiled by Bloomberg.
The average price target of nearly $50 implies about 22% upside from where ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.